Literature DB >> 24327792

A simple one-pot 2-step N-1-alkylation of indoles with α-iminoketones toward the expeditious 3-step synthesis of N-1-quinoxaline-indoles.

Guillermo Martinez-Ariza1, Muhammad Ayaz, Christopher Hulme.   

Abstract

A straightforward procedure for the preparation of N-quinoxaline-indoles is presented. A base-catalyzed one-pot addition of indoles to a preformed α-iminoketone proceeds on the N-1 indole and the subsequent adduct undergoes an acid-mediated deprotection of an internal amino nucleophile, intramolecular cyclization and final oxidation generating N-1-quinoxaline-indoles in good yield.

Entities:  

Keywords:  Indole; Multicomponent reaction; Privileged scaffolds; Quinoxaline; α-iminoketone

Year:  2013        PMID: 24327792      PMCID: PMC3855464          DOI: 10.1016/j.tetlet.2013.09.113

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  17 in total

1.  New catalytic approaches in the stereoselective Friedel-Crafts alkylation reaction.

Authors:  Marco Bandini; Alfonso Melloni; Achille Umani-Ronchi
Journal:  Angew Chem Int Ed Engl       Date:  2004-02-01       Impact factor: 15.336

2.  Treatment of acute cluster headache with sumatriptan.

Authors: 
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

3.  Highly enantioselective Friedel-Crafts reaction of indoles with imines by a chiral phosphoric acid.

Authors:  Qiang Kang; Zhuo-An Zhao; Shu-Li You
Journal:  J Am Chem Soc       Date:  2007-02-14       Impact factor: 15.419

4.  General one-pot, two-step protocol accessing a range of novel polycyclic heterocycles with high skeletal diversity.

Authors:  Zhigang Xu; Muhammad Ayaz; Alexandra A Cappelli; Christopher Hulme
Journal:  ACS Comb Sci       Date:  2012-07-12       Impact factor: 3.784

5.  Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.

Authors:  Douglas E Jorenby; J Taylor Hays; Nancy A Rigotti; Salomon Azoulay; Eric J Watsky; Kathryn E Williams; Clare B Billing; Jason Gong; Karen R Reeves
Journal:  JAMA       Date:  2006-07-05       Impact factor: 56.272

Review 6.  Privileged scaffolds for library design and drug discovery.

Authors:  Matthew E Welsch; Scott A Snyder; Brent R Stockwell
Journal:  Curr Opin Chem Biol       Date:  2010-03-18       Impact factor: 8.822

7.  Comparison of zafirlukast (Accolate) absorption after oral and colonic administration in humans.

Authors:  J D Fischer; M H Song; A B Suttle; W D Heizer; C B Burns; D L Vargo; K L Brouwer
Journal:  Pharm Res       Date:  2000-02       Impact factor: 4.200

8.  Ugi/aldol sequence: expeditious entry to several families of densely substituted nitrogen heterocycles.

Authors:  Zhigang Xu; Fabio De Moliner; Alexandra P Cappelli; Christopher Hulme
Journal:  Angew Chem Int Ed Engl       Date:  2012-06-29       Impact factor: 15.336

Review 9.  Recent advances in the design, synthesis, and biological evaluation of selective DYRK1A inhibitors: a new avenue for a disease modifying treatment of Alzheimer's?

Authors:  Breland Smith; Federico Medda; Vijay Gokhale; Travis Dunckley; Christopher Hulme
Journal:  ACS Chem Neurosci       Date:  2012-08-28       Impact factor: 4.418

10.  The design, synthesis, and evaluation of 8 hybrid DFG-out allosteric kinase inhibitors: a structural analysis of the binding interactions of Gleevec, Nexavar, and BIRB-796.

Authors:  Justin Dietrich; Christopher Hulme; Laurence H Hurley
Journal:  Bioorg Med Chem       Date:  2010-06-04       Impact factor: 3.641

View more
  2 in total

Review 1.  Recent advances in the application of indoles in multicomponent reactions.

Authors:  Ghodsi Mohammadi Ziarani; Razieh Moradi; Tahereh Ahmadi; Negar Lashgari
Journal:  RSC Adv       Date:  2018-03-28       Impact factor: 4.036

2.  Direct synthesis of 2-oxo-acetamidines from methyl ketones, aromatic amines and DMF via copper-catalyzed C(sp3)-H amidination.

Authors:  Dianke Xie; Wei He; Jiang Xiao; Yao Wu; Yongjia Guo; Qiang Liu; Cancheng Guo
Journal:  RSC Adv       Date:  2019-03-04       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.